ESPE Abstracts (2023) 97 P2-88

ESPE2023 Poster Category 2 Multisystem Endocrine Disorders (11 abstracts)

A glimpse of the presentation of Pseudohypoparathyroidism in children.A Case series from a tertiary care Pediatric Endocrine center in Sri Lanka.

Dilhara Gamage 1 , Imalka Jayasundara 2 , Dinendra Siriwardana 1 & Navoda Atapattu 1


1Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. 2Lady Ridgeway Hospital forChildren, Colombo, Sri Lanka


Background: Pseudohypoparathyroidism (PHP) is a condition primarily caused by impaired hormonal signaling through the stimulatory G protein (G2 alpha) for the activation of adenyl cyclase, which is coupled to G protein receptors(1). This occurs due to the molecular defects in the receptors related to the alpha subunit. (1–3). The condition results in resistance to Parathyroid hormone (PTH) and other hormones. Less than 60 cases have been reported worldwide up to December 2016(1) as the condition is rare. Pseudohypoparathyroidism is a spectrum characterized by abnormal physical characteristics, neurocognitive impairment, and multiple endocrine abnormalities. Young children may remain asymptomatic, and disease may manifest in mid or late childhood along with the growth(1). Several subtypes of pseudohypoparathyroidism are being described in the literature. We describe 8 patients diagnosed with PHP and followed up in the endocrinology clinic at Lady Ridgeway Hospital for Children Sri Lanka.

Case presentation: Patient 1 presented with hypertension and short stature. Patients 2-5 presented with hypocalcemia. Inpatient 2 hypocalcemia was incidentally detected on routine investigations. Patient 3 presented with carpopedal spasms and patients 4 and 5 presented with hypocalcemia seizures. Patients 6-8 were evaluated for short stature. At presentation 3 of them were diagnosed with hypothyroidism during the neonatal period or early infancy. The age of diagnosis ranges from 7 months to 10 years. All the patients were diagnosed on the basis of the clinical criteria as genetic testing is not available in the country.

Patient Corrected Ca(mmol/l) P(mmol/l) ALP(IU/l) PTH (pmol/l) (1.6-7.9) Vitamin D nmo/l (50-120) Other
1 2.5 1.54 254 138 77 AHO, brachydactyly, advanced bone age, hypertension
2 1.68 1.8 287 122 55
3 1.6 1.77 321 135.6 43
4 1.31 2.1 258 170 65 Developmental delay, advanced bone age, AHO, brachydactyly
5 1.6 1.9 276 154 84 TSH resistance, GH deficiency, AHO, brachydactyly.
6 1.7 1.97 322 165 53 TSH resistance. AHO
7 1.84 2.3 265 174 62 TSH resistance, GH deficiency, AHO, brachydactyly, advanced bone age
8 2.45 2.1 248 68 48 AHO, Brachydactyly, advanced bone age

Conclusion: Pseudohypoparathyroidism is an important diagnosis that needs high clinical suspicion as the clinical symptoms evolve with time and have a wide spectrum in presentation. The diagnosis can be made clinically. Genetic testing is important in subclassification and counseling. These patients should be referred to a Paediatric endocrinologist for further evaluation and management.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.